
MedFIT Weight Loss and Wellness operates as a medically supervised weight management and men's testosterone clinic at 684 Park St in Belmont, North Carolina, under the clinical direction of Valerie Scheid, MSN, APRN, AGNP-C. The practice concentrates on two primary service lines: GLP-1 receptor agonist therapy for weight reduction and testosterone replacement protocols for male patients experiencing hypogonadism or age-related hormonal decline. Patients seeking weight management solutions in the greater Charlotte metropolitan area access evidence-based pharmacotherapy combined with metabolic monitoring at this Belmont location, which maintains in-person consultation requirements for all new patients and medication initiation.
The clinic's weight loss program centers on Semaglutide and Tirzepatide administration, both FDA-approved GLP-1 medications that regulate appetite and glucose metabolism. Semaglutide dosing typically begins at 0.25 mg weekly with gradual titration based on individual tolerance and response, while Tirzepatide protocols start at 2.5 mg weekly with similar adjustment parameters. Valerie Scheid conducts comprehensive metabolic assessments before initiating either medication, including baseline hemoglobin A1c, lipid panels, thyroid function studies, and blood pressure evaluation. Patients receive detailed education on injection technique, expected side effects such as nausea or gastrointestinal changes, and dietary modifications that enhance medication efficacy. The practice schedules follow-up visits at four-week intervals during the initial titration phase, with ongoing monitoring adjusted based on individual progress and any adverse reactions requiring dose modification.
Valerie Scheid brings Adult-Gerontology Nurse Practitioner certification to her clinical practice, having completed advanced training in metabolic disorders and hormone replacement therapy. Her approach emphasizes patient education regarding the physiological mechanisms of GLP-1 medications and testosterone therapy, ensuring individuals understand how these treatments affect insulin sensitivity, satiety signaling, muscle preservation, and cardiovascular risk factors. For men's health patients, the clinic provides testosterone level assessment through serum testing, evaluation of symptoms including fatigue and decreased libido, and individualized replacement protocols using injection or alternative delivery methods. Scheid addresses common patient concerns about medication costs, insurance coverage limitations, and long-term treatment sustainability during initial consultations, providing transparent pricing information and discussing both brand-name and compounded medication options available through the Belmont clinic.
Patients attending MedFIT in Belmont, North Carolina undergo structured intake appointments that include medical history review, current medication assessment, and discussion of weight loss or hormone therapy goals. The clinic requires in-person visits for treatment initiation and periodic monitoring, though some follow-up consultations may accommodate scheduling flexibility for established patients demonstrating stable response to therapy. Weight management patients receive guidance on nutrition strategies that complement GLP-1 therapy, including protein intake recommendations to preserve lean muscle mass during caloric restriction and hydration protocols to minimize gastrointestinal side effects. Men receiving testosterone therapy undergo periodic hematocrit monitoring to assess for polycythemia risk and prostate-specific antigen testing according to age-appropriate screening guidelines. The practice maintains communication channels for patients experiencing questions about dosage adjustments, side effect management, or treatment expectations between scheduled appointments.
MedFIT's location on Park Street in Belmont provides accessible medical weight loss and men's health services to residents of Gaston County and surrounding communities in the Charlotte region. The clinic's focus on two specific treatment modalities—GLP-1 medications for weight reduction and testosterone replacement for male hypogonadism—allows for concentrated clinical expertise in these areas rather than diffuse service offerings. Valerie Scheid's practice model emphasizes realistic outcome discussions, acknowledging that individual responses to Semaglutide and Tirzepatide vary based on metabolic factors, adherence patterns, and concurrent lifestyle modifications. Patients considering treatment at this Belmont clinic should prepare for initial consultations that include laboratory work requirements, discussion of contraindications such as personal or family history of medullary thyroid carcinoma for GLP-1 candidates, and establishment of measurable health objectives beyond simple weight or testosterone number targets.
Valerie Scheid· MSN, APRN, AGNP-C
Valerie Scheid, MSN, APRN, AGNP-C
Provider
Valerie Scheid is a healthcare provider with extensive experience in weight loss and wellness.
Topics Mentioned in Reviews
Weight Loss Packages
Includes 4 injections and free lab work.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.